Antibodies (3)

Anti-Mouse IFN gamma Antibody

Reference: HY-P99136

€0.00 (tax incl.)

Anti-Mouse IFN gamma Antibody is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster.

Timolumab

Reference: HY-P99323

€0.00 (tax incl.)

Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases.

Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. Among them, OX40 is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells.

Ontuxizumab

Reference: HY-P99778

€0.00 (tax incl.)

Ontuxizumab (MORAb-004) is a humanized IgG1/κ anti-endosialin (TEM-1 or CD248) monoclonal antibody with antitumor effects. Ontuxizumab can be used for the research of cancer.

Guselkumab

Reference: HY-P9931

€0.00 (tax incl.)

Guselkumab is a recombinant human IgG1 monoclonal antibody against the IL-23p19 subunit. Guselkumab binds to human and cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab inhibits...

Ranevetmab

Reference: HY-P99820

€0.00 (tax incl.)

Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain.

Vofatamab

Reference: HY-P99384

€0.00 (tax incl.)

Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial...

Ozoralizumab

Reference: HY-P99796

€0.00 (tax incl.)

Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody....

Dacetuzumab

Reference: HY-P99015

€0.00 (tax incl.)

Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and...

Nipocalimab

Reference: HY-P99037

€0.00 (tax incl.)

Nipocalimab (M281) is a fully human, recombinant, aglycosylated IgG1 monoclonal antibody. Nipocalimab is a human deglycosylated IgG1 anti-FcRn monoclonal antibody that binds with picomolar affinity to Fc receptor...

Atezolizumab

Reference: HY-P9904

€0.00 (tax incl.)

Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.

Detumomab

Reference: HY-P99851

€0.00 (tax incl.)

Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).

Melredableukin alfa

Reference: HY-P99728

€0.00 (tax incl.)

Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of...

Amlitelimab

Reference: HY-P99434

€0.00 (tax incl.)

Alvircept sudotox is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Alvircept sudotox inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis.

Garadacimab

Reference: HY-P99631

€0.00 (tax incl.)

Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.

Ipafricept

Reference: HY-P99667

€0.00 (tax incl.)

Ipafricept (OMP-54F28; FZD8-Fc) is the first class of recombinant fusion proteins, consisting of the extracellular portion of the human fried-8 receptor fused to the Fc fragment of human IgG1 binding to the Wnt...

Rivabazumab

Reference: HY-P99953

€0.00 (tax incl.)

Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV.

Lebrikizumab

Reference: HY-P99025

€0.00 (tax incl.)

Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma.

Topsalysin

Reference: HY-P99554

€0.00 (tax incl.)

Topsalysin (PRX-302; PRX302; PSA-PAH1) is a PSA-activated protoxin, a pore-forming protein (synthetic proaerolysin) fusion protein with human prostate-specific antigen. Topsalysin has tumor suppression effect in mice...

Anti-Mouse NK1.1 Antibody

Reference: HY-P99143

€0.00 (tax incl.)

Anti-Mouse NK1.1 Antibody is an anti-mouse NK1.1 IgG2a antibody inhibitor derived from host mouse.

Fremanezumab

Reference: HY-P99019

€0.00 (tax incl.)

Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral...

Burfiralimab

Reference: HY-P99490

€0.00 (tax incl.)

Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced...

Nebacumab

Reference: HY-P99751

€0.00 (tax incl.)

Nebacumab (HA-1A) is a monoclonal antibody that binds to lipid A portion of endotoxin. Nebacumab can be used of research of sepsis.

Omfiloctocog alfa

Reference: HY-P99769

€0.00 (tax incl.)

Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII). FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the...

Panobacumab

Reference: HY-P99214

€0.00 (tax incl.)

Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa.

Ontamalimab

Reference: HY-P99411

€0.00 (tax incl.)

Ontamalimab (SHP647) is a fully-human IgG2 monoclonal antibody targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Ontamalimab can be used for the research of Crohn's disease.

Anbenitamab

Reference: HY-P99437

€0.00 (tax incl.)

Anbenitamab (KN-026) is a bispecific antibody simultaneously targeting the extracellular domains II and IV of the human HER2. Anbenitamab blocks both ligand-dependent and ligand-independent HER2 signaling pathway. The...

Naxitamab

Reference: HY-P99206

€0.00 (tax incl.)

Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.

Anetumab

Reference: HY-P99352

€0.00 (tax incl.)

Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab...

Dupilumab

Reference: HY-P9926

€0.00 (tax incl.)

Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.

Vapaliximab

Reference: HY-P99526

€0.00 (tax incl.)

Vapaliximab (2D10) is a monoclonal antibody against human VAP-1.

Cetuximab

Reference: HY-P9905

€0.00 (tax incl.)

Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.

Ensituximab

Reference: HY-P99362

€0.00 (tax incl.)

Ensituximab (NEO-102; NPC-1C) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC. Ensituximab shows specificity to colorectal and pancreatic cancer.

Tozorakimab

Reference: HY-P99550

€0.00 (tax incl.)

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease.

Erenumab

Reference: HY-P9938

€0.00 (tax incl.)

Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.

Rocatinlimab

Reference: HY-P99955

€0.00 (tax incl.)

Rocatinlimab (AMG 451) (KHK4083) is a fully human, non-fucosylated, immunoglobulin G1 (IgG1) anti-OX40 monoclonal antibody. Rocatinlimab can be used for the research of atopic dermatitis (AD).

Tagitanlimab

Reference: HY-P99544

€0.00 (tax incl.)

Tagitanlimab (HBM-9167) is a humanized anti-PD-L1 antibody (IgG1κ type). Tagitanlimab selectively blocks the interaction of PD-L1 and PD-1. Tagitanlimab has the potential to be studied in recurrent or metastatic...

Matuzumab

Reference: HY-P9969

€0.00 (tax incl.)

Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth.

Ianalumab

Reference: HY-P99653

€0.00 (tax incl.)

Ianalumab (VAY-736) is a humanized, decarboxylated antibody against BAFF-R. Ianalumab can block the interaction between BAFF and BAFF-R and antagonize the apoptosis protection mediated by BAFF. Ianalumab exerts...

Voxalatamab

Reference: HY-P99517

€0.00 (tax incl.)

Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research.

Lecanemab

Reference: HY-P99689

€0.00 (tax incl.)

Lecanemab (BAN-2401) is an IgG1 anti-soluble aggregated amyloid beta (Aβ) monoclonal antibody. Lecanemab shows activity across oligomers, protofibrils and insoluble fibrils. Lecanemab can be used for the research of...

Nurulimab

Reference: HY-P99760

€0.00 (tax incl.)

Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) humanized monoclonal antibody. Nurulimab can be can be used in research of melanoma.

Gefurulimab

Reference: HY-P99638

€0.00 (tax incl.)

Gefurulimab (ALXN-1720) is a human-derived bispecific antibody against complement C5 and albumin that binds C5 and blocks its activation.

Toralizumab

Reference: HY-P99325

€0.00 (tax incl.)

Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells,...

Obrindatamab

Reference: HY-P99762

€0.00 (tax incl.)

Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells....

Alirocumab

Reference: HY-P9928

€0.00 (tax incl.)

Alirocumab (REGN 727) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein...

Bedinvetmab

Reference: HY-P99297

€0.00 (tax incl.)

Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor...

Mavrilimumab

Reference: HY-P99031

€0.00 (tax incl.)

Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF...

Ripertamab

Reference: HY-P99952

€0.00 (tax incl.)

Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).

Dilpacimab

Reference: HY-P99852

€0.00 (tax incl.)

Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer.

Anti-Mouse CD209b Antibody

Reference: HY-P99122

€0.00 (tax incl.)

Anti-Mouse CD209b Antibody is an anti-mouse CD209b IgG1 antibody inhibitor derived from the host Armenian Hamster.

Nadunolimab

Reference: HY-P99235

€0.00 (tax incl.)

Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer.

Ruplizumab

Reference: HY-P99315

€0.00 (tax incl.)

Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research.

Efalizumab

Reference: HY-P9947

€0.00 (tax incl.)

Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to...

Simlukafusp alfa

Reference: HY-P99902

€0.00 (tax incl.)

Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1.

Abrezekimab

Reference: HY-P99417

€0.00 (tax incl.)

Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in...

Losatuxizumab

Reference: HY-P99715

€0.00 (tax incl.)

Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody. Losatuxizumab binds to EGFR with EC50s of 0.96 nM for EGFR wild-type, 0.09 nM for EGFRC271A,C283A, 0.12 nM for EGFRvIII, 0.66 nM for EGFR1-501....

Osocimab

Reference: HY-P99794

€0.00 (tax incl.)

Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time....

Fresolimumab

Reference: HY-P99020

€0.00 (tax incl.)

Fresolimumab (GC1008) is a high-affinity fully human monoclonal antibody that neutralizes the active form of human TGFβ1, TGFβ2, and TGFβ3. Fresolimumab can be used for the research of cancer and fibrotic diseases .

Sotrovimab

Reference: HY-P99340

€0.00 (tax incl.)

Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long...

Porgaviximab

Reference: HY-P99784

€0.00 (tax incl.)

Porgaviximab is a monoclonal antibody that can be used Ebola infection research.

Atoltivimab

Reference: HY-P99343

€0.00 (tax incl.)

Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.

Bifarcept

Reference: HY-P99478

€0.00 (tax incl.)

Bifarcept is a recombinant antibody of interferon receptor type I (IFN-RI). Bifarcept can bind IFN-β and prolong its serum half-life.

Zamerovimab

Reference: HY-P99513

€0.00 (tax incl.)

Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to...

Olokizumab

Reference: HY-P99210

€0.00 (tax incl.)

Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA).

KY-1044

Reference: HY-P99431

€0.00 (tax incl.)

KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 antibody targeting inducible costimulatory receptor (ICOS). KY-1044 depletes ICOShigh cells via antibody-dependent cellular cytotoxicity (ADCC) through the...

Pexelizumab

Reference: HY-P99886

€0.00 (tax incl.)

Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of...

Tositumomab

Reference: HY-P99326

€0.00 (tax incl.)

Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes.

Luspatercept

Reference: HY-P99720

€0.00 (tax incl.)

Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of...

Begelomab

Reference: HY-P99466

€0.00 (tax incl.)

Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy.

TSR-033

Reference: HY-P99387

€0.00 (tax incl.)

TSR-033 is a high affinity human IgG4 antibody targeting LAG-3 (lymphocyte activation gene-3), a co-receptor associated with impaired T cell function and often co-expressed with PD-1, that enhances T cell function and...

Emapalumab

Reference: HY-P99191

€0.00 (tax incl.)

Emapalumab (NI-0501) is a humanized monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab...

Lenvervimab

Reference: HY-P99693

€0.00 (tax incl.)

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection.

Ponezumab

Reference: HY-P99216

€0.00 (tax incl.)

Ponezumab (PF-04360365) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory....

Tabituximab barzuxetan

Reference: HY-P99581

€0.00 (tax incl.)

Tabituximab barzuxetan (OTSA101-DTPA-90Y) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101), and labeled with Yttrium 90. Tabituximab barzuxetan shows antineoplastic...

Nivolumab

Reference: HY-P9903

€0.00 (tax incl.)

Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.

Apitegromab

Reference: HY-P99441

€0.00 (tax incl.)

Apitegromab (SRK-015) is an anti-promyostatin monoclonal antibody. Apitegromab can be used for the research of neuromuscular disease including spinal muscular atrophy.

Bapineuzumab

Reference: HY-P99185

€0.00 (tax incl.)

Bapineuzumab is an anti-β-amyloid protein (APP) monoclonal antibody. Bapineuzumab can be used for the research of Alzheimer’s disease (AD).

Sirexatamab

Reference: HY-P99906

€0.00 (tax incl.)

Sirexatamab is an active peptide. Sirexatamab can be used for various biochemical studies.

Eftilagimod alfa

Reference: HY-P99933

€0.00 (tax incl.)

Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can...

Camoteskimab

Reference: HY-P99491

€0.00 (tax incl.)

Camoteskimab (AVTX-007) is a fully human, high-affinity anti-IL-18 monoclonal antibody. Camoteskimab has the potential for the autoinflammatory diseases research, including adult-onset Still’s disease (AOSD).

Sonepcizumab

Reference: HY-P99318

€0.00 (tax incl.)

Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC).

Bavunalimab

Reference: HY-P99354

€0.00 (tax incl.)

Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.

Aselizumab

Reference: HY-P99443

€0.00 (tax incl.)

Aselizumab (HuDreg-55) is an humanized IgG4 mAb against L-selectin. However, L-selectin (CD62L) is a cell adhesion molecule expressed on circulating neutrophils. It regulates migrating cells to chemotaxis towards the...

Lupartumab

Reference: HY-P99718

€0.00 (tax incl.)

Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980.

Tislelizumab

Reference: HY-P99052

€0.00 (tax incl.)

Tislelizumab, a monoclonal antibody with high binding affinity to the PD-1 receptor, minimizes Fcγ receptor binding on macrophages, thereby abrogating antibody-dependent phagocytosis, a mechanism of T cell clearance...

Valanafusp alfa

Reference: HY-P99530

€0.00 (tax incl.)

Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the...

Polatuzumab

Reference: HY-P99042

€0.00 (tax incl.)

Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used...

Adebrelimab

Reference: HY-P99422

€0.00 (tax incl.)

Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC).

Zalifrelimab

Reference: HY-P99514

€0.00 (tax incl.)

Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.

Camrelizumab

Reference: HY-P9971

€0.00 (tax incl.)

Camrelizumab (SHR-1210) is a potent humanied high-affinity IgG4-κ monoclonal antibody (mAb) to PD-1. Camrelizumab binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an...

Finotonlimab

Reference: HY-P99619

€0.00 (tax incl.)

Finotonlimab (SCT-I10A) is a recombinant humanised IgG PD-1 antibody. Finotonlimab has the potential for solid tumors or lymphomas research.

Racotumomab

Reference: HY-P99254

€0.00 (tax incl.)

Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in...

Ifabotuzumab

Reference: HY-P99655

€0.00 (tax incl.)

Ifabotuzumab (KB004) is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab induces tumor cell apoptosis, activates Antibody-dependent cell mediated cytotoxicity (ADCC), and damages tumor vasculature....

Odronextamab

Reference: HY-P99038

€0.00 (tax incl.)

Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells.

Secukinumab

Reference: HY-P9927

€0.00 (tax incl.)

Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing...

Nesvacumab

Reference: HY-P99036

€0.00 (tax incl.)

Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Angiopoietin-2 (Ang2) with high affinity, but shows no binding to Ang1.

Tiragolumab

Reference: HY-P9986

€0.00 (tax incl.)

Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab, may be effective against multiple...

Rosopatamab

Reference: HY-P99239

€0.00 (tax incl.)

Rosopatamab (HJ 591) is a humanised anti-PSMA monoclonal antibody that can be used in cancer research, particularly in prostate cancer.

Cendakimab

Reference: HY-P99496

€0.00 (tax incl.)

Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and...

Category: Antibodies

Menu

Settings